U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula F.Na
Molecular Weight 40.99070695
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM FLUORIDE F-18

SMILES

[18F-].[Na+]

InChI

InChIKey=PUZPDOWCWNUUKD-ULWFUOSBSA-M
InChI=1S/FH.Na/h1H;/q;+1/p-1/i1-1;

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula FH
Molecular Weight 19.00888
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

FLUORIDE ION F-18 (as sodium fluoride F-18) is a radioactive diagnostic agent for positron emission tomography (PET) indicated for imaging of bone to define areas of altered osteogenic activity. FLUORIDE ION F-18 normally accumulates in the skeleton in an even fashion, with greater deposition in the axial skeleton (e.g. vertebrae and pelvis) than in the appendicular skeleton and greater deposition in the bones around joints than in the shafts of long bones. Increased FLUORIDE ION F-18 deposition in the bone can occur in areas of increased osteogenic activity during growth, infection, malignancy (primary or metastatic) following trauma, or inflammation of the bone.

Approval Year

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
SODIUM FLUORIDE F-18

Sample Use Guides

In Vivo Use Guide
Administer 300-450 MBq (8–12 mCi) as an intravenous injection in adults.
Route of Administration: Intravenous
Substance Class Chemical
Record UNII
9L75099X6R
Record Status Validated (UNII)
Record Version